Luye Pharma Brings Hillhouse on Board as a Strategic Investor to Accelerate Innovation and Global Development - Global Collaboration

Products>Global Collaboration

Luye Pharma Brings Hillhouse on Board as a Strategic Investor to Accelerate Innovation and Global Development

February 08,2021

In February 2021, Luye Pharma received a strategic investment worth HK$2.4 billion from Hillhouse, while Hillhouse was granted a 15.60% stake in Luye Pharma.
As one of Asia’s leading venture capital and private equity investment organizations, Hillhouse seeks long-term growth with Luye Pharma by investing in the development of its existing strategies.
With the support of Hillhouse, Luye Pharma will accelerate implementation of its corporate strategic focus on ‘innovation’ and ‘globalization’. Leveraging the strength of its innovative technology platforms, the company will enhance R&D capabilities, further develop its expertise in cutting-edge technologies, accelerate new product launches and expand its business capabilities in global markets.

Products>Global Collaboration

Luye Pharma Brings Hillhouse on Board as a Strategic Investor to Accelerate Innovation and Global Development

February 08,2021

In February 2021, Luye Pharma received a strategic investment worth HK$2.4 billion from Hillhouse, while Hillhouse was granted a 15.60% stake in Luye Pharma.
As one of Asia’s leading venture capital and private equity investment organizations, Hillhouse seeks long-term growth with Luye Pharma by investing in the development of its existing strategies.
With the support of Hillhouse, Luye Pharma will accelerate implementation of its corporate strategic focus on ‘innovation’ and ‘globalization’. Leveraging the strength of its innovative technology platforms, the company will enhance R&D capabilities, further develop its expertise in cutting-edge technologies, accelerate new product launches and expand its business capabilities in global markets.